Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brada

Showing results (251-260 of 258) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 258 results.
Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 13, 2021
Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinomaLois A Daamen, Galina Dorland, Lilly J H Brada, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 14, 2020
The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registryL J H Brada, M S Walma, R M van Dam, et al.
Annals of Surgery|July 21, 2023
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter StudyLeonard W F Seelen, Deesje Doppenberg, Thomas F Stoop, et al.
Neuro-Oncology Advances|November 29, 2023
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphomaKarl-Heinz Nenning, Johanna Gesperger, Julia Furtner, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohortMarieke S Walma, Lilly J Brada, Susana I S Patuleia, et al.
JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.
Pageof 26

Showing results (251-260 of 258) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
Annals of Surgery|August 2, 2021
Survival Benefit Associated With Resection of Locally Advanced Pancreatic Cancer After Upfront FOLFIRINOX Versus FOLFIRINOX Only: Multicenter Propensity Score-matched AnalysisLilly J H Brada, Lois A Daamen, Lisa G Magermans, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 13, 2021
Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinomaLois A Daamen, Galina Dorland, Lilly J H Brada, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|December 14, 2020
The treatment and survival of elderly patients with locally advanced pancreatic cancer: A post-hoc analysis of a multicenter registryL J H Brada, M S Walma, R M van Dam, et al.
Annals of Surgery|July 21, 2023
Minimum and Optimal CA19-9 Response After Two Months Induction Chemotherapy in Patients With Locally Advanced Pancreatic Cancer: A Nationwide Multicenter StudyLeonard W F Seelen, Deesje Doppenberg, Thomas F Stoop, et al.
Neuro-Oncology Advances|November 29, 2023
Radiomic features define risk and are linked to DNA methylation attributes in primary CNS lymphomaKarl-Heinz Nenning, Johanna Gesperger, Julia Furtner, et al.
Trials|April 30, 2021
Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trialM S Walma, S J Rombouts, L J H Brada, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 7, 2020
Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohortMarieke S Walma, Lilly J Brada, Susana I S Patuleia, et al.
JAMA Network Open|March 31, 2026
Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical TrialLeonard W F Seelen, Lilly J H Brada, Marieke S Walma, et al.
Pageof 26